AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Introduction
Exploring the ASH 2018 guidelines for VTE management, the superiority of DO-ACs over warfarin, and considerations for selecting DO-ACs based on criteria and cost differences. The chapter also covers instances where warfarin may still be preferred and details on approved DO-ACs in Canada for VTE treatment.